NVOC
Get informed when a big investor buys or sells
+ Follow| Market cap | $344,004.00 |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $- (NaN%) |
| Earnings per Share | $- |
| Beta | 0 |
| Outstanding Shares | - |
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
NVOC seeks to deliver 200% of the daily performance of Novo Nordisk A/S (NYSE: NVO) through derivatives such as swap agreements and exchange-traded equity futures to create leveraged exposure. Novo Nordisk A/S is a healthcare company tha...